Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan.

Yamaba Y, Ito Y, Suzuki K, Kikuchi T, Ogawa K, Fujiuchi S, Hasegawa N, Kurashima A, Higuchi T, Uchiya KI, Watanabe A, Niimi A.

J Infect Chemother. 2019 Jun 22. pii: S1341-321X(19)30163-1. doi: 10.1016/j.jiac.2019.05.028. [Epub ahead of print]

PMID:
31239192
2.

Biochemical and cellular activity of chemically synthesized elastase inhibitor (S-AFUEI) from Aspergillus fumigatus.

Fukui Y, Okumura Y, Uchiya K, Komori Y, Ogawa K, Nikai T, Hasegawa Y.

J Mycol Med. 2019 Sep 24:100877. doi: 10.1016/j.mycmed.2019.05.001. [Epub ahead of print]

PMID:
31151871
3.

Salmonella Fimbrial Protein FimH Is Involved in Expression of Proinflammatory Cytokines in a Toll-Like Receptor 4-Dependent Manner.

Uchiya KI, Kamimura Y, Jusakon A, Nikai T.

Infect Immun. 2019 Feb 21;87(3). pii: e00881-18. doi: 10.1128/IAI.00881-18. Print 2019 Mar.

4.

Antibiotic Susceptibility and Genotyping of Mycobacterium avium Strains That Cause Pulmonary and Disseminated Infection.

Uchiya KI, Asahi S, Futamura K, Hamaura H, Nakagawa T, Nikai T, Ogawa K.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02035-17. doi: 10.1128/AAC.02035-17. Print 2018 Apr.

5.

Comparative genome analyses of Mycobacterium avium reveal genomic features of its subspecies and strains that cause progression of pulmonary disease.

Uchiya KI, Tomida S, Nakagawa T, Asahi S, Nikai T, Ogawa K.

Sci Rep. 2017 Jan 3;7:39750. doi: 10.1038/srep39750.

6.

ASSOCIATION BETWEEN A pMAH135 PLASMID AND THE PROGRESSION OF PULMONARY DISEASE CAUSED BY MYCOBACTERIUM AVIUM.

Moriyama M, Ogawa K, Nakagawa T, Nikai T, Uchiya K.

Kekkaku. 2016 Jan;91(1):9-15.

PMID:
27192775
7.

Genetic diversity of clinical Mycobacterium avium subsp. hominissuis and Mycobacterium intracellulare isolates causing pulmonary diseases recovered from different geographical regions.

Ichikawa K, van Ingen J, Koh WJ, Wagner D, Salfinger M, Inagaki T, Uchiya KI, Nakagawa T, Ogawa K, Yamada K, Yagi T.

Infect Genet Evol. 2015 Dec;36:250-255. doi: 10.1016/j.meegid.2015.09.029. Epub 2015 Oct 3.

PMID:
26435330
8.

Characterization of a novel plasmid, pMAH135, from Mycobacterium avium subsp. hominissuis.

Uchiya K, Takahashi H, Nakagawa T, Yagi T, Moriyama M, Inagaki T, Ichikawa K, Nikai T, Ogawa K.

PLoS One. 2015 Feb 11;10(2):e0117797. doi: 10.1371/journal.pone.0117797. eCollection 2015.

9.

Okinalysin, a novel P-I metalloproteinase from Ovophis okinavensis: biological properties and effect on vascular endothelial cells.

Komori Y, Murakami E, Uchiya K, Nonogaki T, Nikai T.

Toxins (Basel). 2014 Aug 25;6(9):2594-604. doi: 10.3390/toxins6092594.

10.

Characterization and identification of partial amino acid sequence of a novel elastase inhibitor, Asnidin from Aspergillus nidulans.

Okumura Y, Suzukawa M, Uchiya K, Ogawa K, Komori Y, Yamashita N, Nikai T.

Med Mycol J. 2013;54(3):279-84.

11.

Comparative genome analysis of Mycobacterium avium revealed genetic diversity in strains that cause pulmonary and disseminated disease.

Uchiya K, Takahashi H, Yagi T, Moriyama M, Inagaki T, Ichikawa K, Nakagawa T, Nikai T, Ogawa K.

PLoS One. 2013 Aug 21;8(8):e71831. doi: 10.1371/journal.pone.0071831. eCollection 2013.

12.

[Extensive genetic analysis of clinical tuberculosis isolates and analysis of host factors to evaluate rapid development of multidrug resistance during initial treatment].

Inagaki T, Nakagawa T, Maeda S, Murase Y, Ichikawa K, Moriyama M, Uchiya K, Yagi T, Nikai T, Ogawa K.

Kekkaku. 2013 Jul;88(7):595-604. Japanese.

PMID:
23986941
13.

X-ray structure analysis and characterization of AFUEI, an elastase inhibitor from Aspergillus fumigatus.

Sakuma M, Imada K, Okumura Y, Uchiya K, Yamashita N, Ogawa K, Hijikata A, Shirai T, Homma M, Nikai T.

J Biol Chem. 2013 Jun 14;288(24):17451-9. doi: 10.1074/jbc.M112.433987. Epub 2013 May 2.

14.

[Multicenter study on clinical features and genetic characteristics of Mycobacterium avium strains from patients in Japan with lung disease caused by M. avium].

Nakagawa T, Takahashi H, Ichikawa K, Inagaki T, Uchiya K, Nikai T, Yagi T, Ogawa K.

Kekkaku. 2012 Nov;87(11):687-95. Japanese.

PMID:
23367826
15.

[Identification of novel variable number tandem repeat (VNTR) loci in Mycobacterium avium and development of an effective means of VNTR typing].

Kurokawa K, Uchiya K, Yagi T, Takahashi H, Niimi M, Ichikawa K, Inagaki T, Moriyama M, Nikai T, Hayashi Y, Nakagawa T, Ogawa K.

Kekkaku. 2012 Jul;87(7):491-9. Japanese.

PMID:
22993890
16.

[A study of genetic characteristics of Mycobacterium avium strains from patients with pulmonary M. avium disease in Japan and Korea].

Niimi M, Uchiya K, Yagi T, Takahashi H, Kurokawa K, Ichikawa K, Inagaki T, Moriyama M, Nikai T, Hayashi Y, Nakagawa T, Ogawa K.

Kekkaku. 2012 Jun;87(6):461-7. Japanese.

PMID:
22834098
17.

High-yields heterologous production of the novel Aspergillus fumigatus elastase inhibitor AFUEI in Aspergillus oryzae.

Yamashita N, Komori Y, Okumura Y, Uchiya K, Matsui T, Nishimura A, Ogawa K, Nikai T.

J Biosci Bioeng. 2011 Aug;112(2):114-7. doi: 10.1016/j.jbiosc.2011.03.020. Epub 2011 May 2.

PMID:
21543256
18.

Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium complex isolates.

Inagaki T, Yagi T, Ichikawa K, Nakagawa T, Moriyama M, Uchiya K, Nikai T, Ogawa K.

J Antimicrob Chemother. 2011 Apr;66(4):722-9. doi: 10.1093/jac/dkq536. Epub 2011 Feb 3.

PMID:
21393190
19.

[Clinical application of line probe assay (LiPA) for rifampicin (RFP)-resistant gene examination in sputum from tuberculosis patients].

Inagaki T, Yagi T, Ichikawa K, Nakagawa T, Moriyama M, Uchiya K, Nikai T, Ogawa K.

Kekkaku. 2010 Sep;85(9):703-9. Japanese.

PMID:
20960950
20.

Isolation and chemical characterization of a toxin isolated from the venom of the sea snake, Hydrophis torquatus aagardi.

Nagamizu M, Komori Y, Uchiya K, Nikai T, Tu AT.

Toxins (Basel). 2009 Dec;1(2):162-72. doi: 10.3390/toxins1020162. Epub 2009 Dec 8.

21.

Comparison of sea snake (Hydrophiidae) neurotoxin to cobra (Naja) neurotoxin.

Komori Y, Nagamizu M, Uchiya K, Nikai T, Tu AT.

Toxins (Basel). 2009 Dec;1(2):151-61. doi: 10.3390/toxins1020151. Epub 2009 Dec 3.

22.

Molecular typing of Mycobacterium intracellulare using multilocus variable-number of tandem-repeat analysis: identification of loci and analysis of clinical isolates.

Ichikawa K, Yagi T, Inagaki T, Moriyama M, Nakagawa T, Uchiya K, Nikai T, Ogawa K.

Microbiology. 2010 Feb;156(Pt 2):496-504. doi: 10.1099/mic.0.030684-0. Epub 2009 Oct 22.

PMID:
19850613
23.

Involvement of SPI-2-encoded SpiC in flagellum synthesis in Salmonella enterica serovar Typhimurium.

Uchiya K, Sugita A, Nikai T.

BMC Microbiol. 2009 Aug 25;9:179. doi: 10.1186/1471-2180-9-179.

24.

Characterization of Mycobacterium avium clinical isolates in Japan using subspecies-specific insertion sequences, and identification of a new insertion sequence, ISMav6.

Ichikawa K, Yagi T, Moriyama M, Inagaki T, Nakagawa T, Uchiya K, Nikai T, Ogawa K.

J Med Microbiol. 2009 Jul;58(Pt 7):945-50. doi: 10.1099/jmm.0.008623-0. Epub 2009 Jun 5.

PMID:
19502362
25.

Comparison of a variable-number tandem-repeat (VNTR) method for typing Mycobacterium avium with mycobacterial interspersed repetitive-unit-VNTR and IS1245 restriction fragment length polymorphism typing.

Inagaki T, Nishimori K, Yagi T, Ichikawa K, Moriyama M, Nakagawa T, Shibayama T, Uchiya K, Nikai T, Ogawa K.

J Clin Microbiol. 2009 Jul;47(7):2156-64. doi: 10.1128/JCM.02373-08. Epub 2009 Apr 29.

26.
27.

Biochemical properties and primary structure of elastase inhibitor AFUEI from Aspergillus fumigatus.

Okumura Y, Matsui T, Ogawa K, Uchiya K, Nikai T.

J Med Microbiol. 2008 Jul;57(Pt 7):803-8. doi: 10.1099/jmm.0.47789-0.

PMID:
18566136
28.

Biological properties of elastase inhibitor, AFLEI from Aspergillus flavus.

Okumura Y, Ogawa K, Uchiya K, Komori Y, Nonogaki T, Nikai T.

Nihon Ishinkin Gakkai Zasshi. 2008;49(2):87-93.

29.

Characterization and primary structure of elastase inhibitor, AFLEI, from Aspergillus flavus.

Okumura Y, Ogawa K, Uchiya K.

Nihon Ishinkin Gakkai Zasshi. 2007;48(1):13-8.

30.

[Usefulness of variable numbers of tandem repeats typing in clinical strains of Mycobacterium avium].

Moriyama M, Ogawa K, Nishimori K, Uchiya K, Ito T, Yagi T, Nakashima I, Nakagawa T, Tarumi O, Nikai T.

Kekkaku. 2006 Sep;81(9):559-66. Japanese.

PMID:
17037388
31.

Isolation and characterization of a novel elastase inhibitor, AFLEI from Aspergillus flavus.

Okumura Y, Ogawa K, Uchiya K, Nikai T.

Nihon Ishinkin Gakkai Zasshi. 2006;47(3):219-24.

32.
35.

A Salmonella virulence protein that inhibits cellular trafficking.

Uchiya K, Barbieri MA, Funato K, Shah AH, Stahl PD, Groisman EA.

EMBO J. 1999 Jul 15;18(14):3924-33.

36.
37.

Identification of a novel virulence gene, virA, on the large plasmid of Shigella, involved in invasion and intercellular spreading.

Uchiya K, Tobe T, Komatsu K, Suzuki T, Watarai M, Fukuda I, Yoshikawa M, Sasakawa C.

Mol Microbiol. 1995 Jul;17(2):241-50.

PMID:
7494473
39.

Isolation and characterization of fibrinogenase from Candida albicans NH-1.

Nikai T, Okumura Y, Hasegawa Y, Uchiya K, Kamiya K, Sugihara H.

Int J Biochem. 1993 Dec;25(12):1815-22.

PMID:
8138020
40.
41.
43.
44.
45.
46.

Enhancing effect of Salmonella enteritidis SPA on nonspecific resistance.

Uchiya K, Sugihara H.

Kansenshogaku Zasshi. 1989 May;63(5):463-70.

PMID:
2550565
47.

[Effect against macrophages of purified SPA of S. enteritidis].

Uchiya K, Kashida M, Sugihara H.

Kansenshogaku Zasshi. 1986 May;60(5):485-94. Japanese. No abstract available.

PMID:
3093604

Supplemental Content

Loading ...
Support Center